122,000-square-foot biomanufacturing facility fully leased to Organogenesis expands firm’s growing life sciences portfolio
BOSTON — Lightstone has acquired a Class A life sciences campus in the Greater Boston region for $68 million, marking a significant expansion of its growing biotechnology and advanced manufacturing portfolio.
The property, located at 100 Technology Way, is a 122,507-square-foot cGMP biomanufacturing facility in the Providence submarket and is fully leased to Organogenesis, a publicly traded regenerative medicine company. The seller was The Davis Companies.
Lightstone said the acquisition aligns with its strategy to invest in high-quality life sciences and technology-focused assets in leading innovation markets. Mitchell Hochberg, president of the firm, noted that demand for specialized biomanufacturing and research space continues to drive growth in the sector, positioning the company to support large-scale innovation.
Originally developed in 1993, the facility has housed several prominent life sciences tenants over the years, including Dow, Alexion, and Rubius Therapeutics. Organogenesis, the current tenant, is known for FDA-approved products such as Apligraf, Dermagraft, and PuraPly, and is investing approximately $100 million to renovate and upgrade the facility.
The transaction was brokered by Newmark’s capital markets team, including Robert Griffin, Jim Tribble, Sam Hallowell, Tyler McGrail, and Will Sleeper.
With the acquisition, Lightstone’s life sciences platform now totals more than 1.2 million square feet across eight assets nationwide, spanning life sciences, medical office, and technology-oriented properties. The firm also has an active pipeline of approximately 1 million square feet in additional life sciences developments across major U.S. markets.
Founded by David Lichtenstein, Lightstone is one of the largest privately held real estate companies in the country, with more than $12 billion in assets under management and a portfolio that includes industrial, residential, hospitality, and commercial properties across 28 states.
